Login
From:
Alzheimer's News Today
(Uncensored)
subscribe
FDA approves donanemab, now Kisunla, to treat early Alzheimer's
https://alzheimersnewstoday.com/news/donanemab-approved-early-symptomatic-alzheimers-now-kisunla/
links
backlinks
Tagged with:
fda approval
donanemab
Eli Lilly's donanemab, now Kisunla, was approved by the U.S. Food and Drug Administration for patients with early symptomatic Alzheimer’s.
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
